An alternative to open repair was initially reported by Parodi in 1991.2) A covered stent was inserted within the aneurysm by an endoluminal route via the femoral artery. About 90 per cent of AAAs can be excluded from the circulation with low risk of subsequent aneurysm rupture, thereby reducing significantly postoperative pain, critical care requirement and hospital stay. 3,4) There are numerous reports on the long-term effects of patients after EVAR, including the DREAM, EVAR1 and EVAR2 studies. [5][6][7][8] These trials showed that EVAR is more likely to be more cost-effective than open repair in terms of operative mortality with no differences in mortality or aneurysm-related mortality existing between both groups in long-term. [5][6][7][8] However, patients undergoing the EVAR procedure have a higher rate of graft-related complications and more costly reinterventions. 8,9)